Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL...LOL....LOL....I loved it!!! eom
Nah !!! I think we will hear something in about 2 weeks. Geez I really do love NWLL/NWL....LOL.....but this 2 weeks stuff just makes me ROFLing.....I know it is not funny, but it does make me giggle.
ljoeo.....Have you heard any news yet about cnbc news coverage?? Did they do one on NWLL? Somebody said that they were doing coverage on companies in Australia.
Mr. Howell what are you talking about. I am here and I am there and I do sleep. When I have something to say I say it. I just have nothing to say right at this time. I am not wearing shackles here or RB. I am free to go anywhere.
Geez....I hope it is not another two weeks...eom
YEP....LOL...LOL....eom
OT Francois...Well not really. They just sort of come in and out all on their own. They go back and forth and that is good also. Thanks for your good wishes. NWLL is looking so much better. I think all will be well with it. We just need about two more weeks....LOL.....just joking. This 2 more week thing is a little tease we have going on NWLL/NWL.
Thanks again
101Dahlias
medicaldave...I tried to get a post to you but it wouldn't take. I guess we were having some tech problems at the time. Anyway what I was trying to explain is the price was pleasingly better to me today and maybe we were out of the slump we have been in and tomorrow may even get better than today AND it is one day closer to hopefully some announcement and that means that it takes me one day closer to their announcing the Share Holders meeting and that means one day closer to my getting to go to Australia........Whew.....LOL see what I mean??? I have been waiting to go to Australia for such a long time. I got my Pass port back in April (I think it was April) Thinking that they would have a meeting in June and I wanted to be ready to go. But, as you can see I still wait.
Will do after dinner...Thanks...ciao...EOM
Today was so good too, I can't wait for tomorrow.
Goooooooooo NWLL/NWL.
FM ..... Thanks, for explaining that...EOM
Yikes !! Sure don't like the sounds of that. Would like to know if you find out.
Thanks for the up date. Maybe things will pick up by Friday.
Doesn't the Olypmics start this Friday ??
Where did everybody go today? eom.
Press Release Monday September 11, 2:35 pm Eastern Time
Scios to Present Five Natrecor Abstracts at 4th Annual Heart Failure Society Meeting
http://biz.yahoo.com/prnews/000911/ca_scios_n.html
Press Release..Monday September 11, 12:55 pm Eastern Time
WebTrends Named Oregon Technology Company of the Year by Oregon Entrepreneurs Forum
WebTrends Honored for Its Innovation, Leadership and Financial Success
http://biz.yahoo.com/bw/000911/or_webtren.html
Ladies and Gentlemen here is what the parking lot is all about and here is the link to get there:
http://www.investorshub.com/beta/board.asp?board_id=37
Please take the argument to the Parking lot. It will not be tolerated at this NWLL message board.
Thank you
101Dahlias
Chairman
=======================================================
The Parking Lot.
Chairman: iHub Sheriff
Created: 5/4/00 11:32:31 PM (ET)
Welcome to the Parking Lot
This area is designed to allow members to vent their anger, settle a dispute, or fight on a particular unavoidable subject so that it stays off the investment discussions.
When posting on the various investment-related boards, we do not promote fights and they often will get deleted. We also look down upon personal attacks and insults. We want you to use this thread as an alternative in order to keep the investment discussions clean and focused.
This forum will be unmoderated and open to all.
So, if you have a problem with somebody, ask them to step out into The Parking Lot.
You assume all responsibility for what you say and do here.
iHub Sheriff
Options: Subscribe to 'The Parking Lot' ChairMail (E-Mail List)
ljoeo....Congratulations.....You did it! Looks very good.
You did a wonderful job ljoeo. I have the best of wishes for you and e-Toys. Keep up the good work.
My best regards
101Dahlias
Pansy010...No one here can advise you what to do with your stock. Perhaps you should seek a professional financial advisor.
Bikeboy...If we all practise good manners and behave like Ladies and Gentlemen everything should work out fine.
Pansy010...Please relax and enjoy the investorshub. You will be just fine.
Here is the link to the NewTel web site:
http://www.newtel-limited.com/newtel/index.html
I think you will find this is a friendly and supportive place.
A pansy is a very pretty flower and a nice name.
Welcome to investorshub and NWLL.
101Dahlias
Chairman
ljoeo..I am happy to see you here. I hope you will enjoy investorshub. In regards to e-toys, I will be happy to assist you. I am sending you a private message in regards to your request. I will send it in just a few minutes. Please watch for the message in your mailbox. Look at the top of this page. The place that says "Mailbox" will show you how many messages you have. Click on it and it will take you to your mailbox.
ALL PLEASE READ !!
Poster Strike21...Your post 129 is viewed as a threat and being removed for review. After review it may or may not be restored.
Strike21, as I am sure you know that I am Chairman of this message board. My mission here is to try to maintain a pleasent message board. I guarantee you that I, for one, will not let my personal feelings enter into any action I take, on anyone, that I feel necessary.
Idle threats, bashing, personal attacks on posters including attacking their spelling and grammar are not welcomed. I expect polite behavior from all.
All are welcome here to exchange NWLL information and PLEASENT conversation with one another. I recommend that all personal attacking or threats, cease and desist immediately. It will not be tolerated, on this message board.
If anyone posting here has a problem with someone, we have a "Parking Lot" area where these problems can be taken. In the "Parking Lot" area one may "Slug it out", so to speak, with one another, until the the problems are or can be resolved.
This is a public forum. All posters are expected to conduct themselves as Ladies and Gentlemen and show good manners and respect for all.
ALL...A Quote Room Is Coming Soon. eom.
Poster of post 128 and 129 Please take it to the Parking lot area. Your past posting history proceeds you here and is not welcomed.
Thank you
101Dahlias
Chairman
Antat...Just came over to say, happy to see the Australian stocks here also. A few people have asked about ACE at the NWLL message board. I know that there are some people at NWLL involved in some of the other stocks you mention here. This board is very good to have. I know that others will be very happy to have this board. Very nice addition.
Enjoy
101Dahlias
Jimmu & ALL RE: Private Messages and Spell check...Open any message. At the bottom of the message area you will see a little icon that says ihub wish list. Click on it. It will take you to a list of things that have been asked for by the members. You can view Matt's responses to the wishers. Click on his message and you may send a message to him in regards to what you would like to have.
Private Messages....A private message can be sent to any poster. This message is not viewed by anyone else except by you. You get to your private messages via your mail box.
I will do my best to keep a low profile on this main message board. I will answer all private messages that anyone sends me. My public messages I will try to keep beneficial to all. I know that I can not please everyone......But I will try to do my best.
Happy Days Are Here Again
101Dahlias
ALL in regard to the OT
We could star an NWLL Off Topic Club here, I do believe. I will check with Matt about it, and report what I have found out. Perhaps one of you would like to be Chairman of the OT board if one is needed. Also FYI...all your messages can be edited by you with in the first 10 minutes to make changes as you need.
Press realeases for WEBT
Tuesday August 29, 5:50 pm Eastern Time
WebTrends Introduces Enhanced WebTrends Live eService, Offering First Real-Time Wireless eCommerce Analysis and Reporting
http://biz.yahoo.com/bw/000829/or_webtren.html
Tuesday August 22, 9:00 am Eastern Time
Individual Investor Names WebTrends Among America's 100 Fastest-Growing Companies
http://biz.yahoo.com/bw/000822/or_webtren.html
Wednesday August 16, 2:54 pm Eastern Time
Grubb & Ellis Represents WebTrends(R) in The Leasing of 58,000 Square Feet at Fox Tower
http://biz.yahoo.com/prnews/000816/il_grubb_e.html
Tuesday August 1, 9:05 am Eastern Time
WebTrends Firewall Suite Solution Garners Additional Industry Support
http://biz.yahoo.com/bw/000801/or_webtren_5.html
Tuesday August 1, 9:00 am Eastern Time
WebTrends Unveils Firewall Suite 3.0, Offering Essential Reporting Solution to Monitor and Analyze Firewall Security and Performance
http://biz.yahoo.com/bw/000801/or_webtren_4.html
Tuesday August 1, 8:59 am Eastern Time
WebTrends Announces Enterprise Suite 5.0
http://biz.yahoo.com/bw/000801/or_webtren_2.html
Tuesday August 1, 8:59 am Eastern Time
WebTrends Firewall Suite 3.0 Adds Support for Sun Microsystems Firewalls
http://biz.yahoo.com/bw/000801/or_webtren_3.html
Tuesday August 1, 8:58 am Eastern Time
WebTrends Enterprise Suite Supports Leading Streaming Media Servers
http://biz.yahoo.com/bw/000801/or_webtren.html
Monday July 24, 9:12 am Eastern Time
marchFIRST HostOne Selects WebTrends Enterprise Reporting Server as Standard Web Visitor Analysis Solution
http://biz.yahoo.com/bw/000724/or_webtren.html
Monday July 24, 8:04 am Eastern Time
New Sybase Strategic Partnerships Will Enhance Web-Based Business Intelligence Solutions
http://biz.yahoo.com/prnews/000724/ca_sybase_.html
Monday July 17, 6:43 pm Eastern Time
WebTrends Top Q2 Expectations (Audio)
http://biz.yahoo.com/oo/000717/30612.html
Monday July 17, 4:15 pm Eastern Time
WebTrends Corporation Reports Record Second Quarter Revenues and Earnings
http://biz.yahoo.com/prnews/000717/or_webtren.html
Wednesday July 12, 11:24 am Eastern Time
Travel Industry Leaders Use WebTrends to Keep Web Site Visitors Moving
http://biz.yahoo.com/bw/000712/or_webtren.html
Wednesday June 28, 9:07 am Eastern Time
WebTrends Corporation Acquires UK Distributor
http://biz.yahoo.com/bw/000628/or_webtren.html
Monday June 26, 5:18 pm Eastern Time
ANGOSS Software Announces Support For CommerceTrends 3.0 Platform From WebTrends
http://biz.yahoo.com/ccn/000626/bk.html
Monday June 26, 9:41 am Eastern Time
WebTrends Launches CommerceTrends 3.0, the Industry's First Platform for Visitor Relationship Management
http://biz.yahoo.com/bw/000626/or_webtren_5.html
Monday June 26, 9:17 am Eastern TimeWebTrends and Vignette Enter Into Alliance to Offer Integrated Visitor Relationship Management Reporting Solution
http://biz.yahoo.com/bw/000626/or_webtren_4.html
Monday June 26, 9:13 am Eastern Time
Sybase and WebTrends Form Strategic Alliance Powered by CommerceTrends 3.0 Platform for Visitor Relationship Management
http://biz.yahoo.com/bw/000626/or_webtren_3.html
Monday June 26, 9:01 am Eastern Time
Industry Leaders Support CommerceTrends 3.0 Platform from WebTrends
http://biz.yahoo.com/bw/000626/or_webtren_2.html
Monday June 26, 9:00 am Eastern Time
WebTrends and Oracle Team to Provide Powerful Visitor Data Mining Solution
http://biz.yahoo.com/bw/000626/or_webtren.html
Wednesday June 21, 9:02 am Eastern Time
WebTrends Live Recognized as Fastest-Growing eBusiness Intelligence ASP
http://biz.yahoo.com/bw/000621/or_webtren.html
Wednesday June 14, 9:15 am Eastern Time
WebTrends Hosts Education Series on Visitor Relationship Management
http://biz.yahoo.com/bw/000614/or_webtren.html
Tuesday June 13, 12:39 pm Eastern Time
WebTrends Log Analyzer 5.0 Named Editors' Choice by PC Magazine
http://biz.yahoo.com/bw/000613/or_webtren.html
Investor....Just noticed that ZSUN was here. Nice to see you investor.
DD...WOW, I just saw the news that the ERA has completed the study on the feasibility study for the undersea resort in Maui.
Also just saw that Cala just signed an agreement with the A.P.O.L
LOL looks like CCAA will be in the "oil" business....OLive that is. I love it Our CEO just never ceases to amaze me. I am so glad that CCAA is here at the investorshub. I love this place.
thirstonhowell, First off ALL are welcome here. As long as they behave in a respectful manner and not Attack any one poster or posters here. Personal attacks are not welcome and the attackers posts will be erased and if the attacker continues in that manner the Attacker will be baned from the message board he/she has attcked on. Please see post #66 it explains it a little better. It also includes a link that explains it completely on what action is taken against the attacker.
I am very sorry if I have disappointed you. However, I did not join a posting forum to become a FIGHTER. I joined to share information and try to be helpful and useful to others if I could. I do not enjoy a forum that has become a constant battle for my rights to post. I am not afraid of my attackers. I just feel that it is not worthy of my time or energy to have to be in a place filled with ill mannered rude people.
Thank you Mr. Howell, however, no thank you. I have no need nore desire to return to Raging Bull. Just tell them that the horse is dead. If it gives them great pleasure to beat a dead horse.....then let the beat go on. It bothers me not.
Mr. Howell, if you tire of the fight and need a breath of fresh air, you are welcome to return anytime you like.
Warm regards and in friendship
101Dahlias
NUTTS and ALL...First off I would like to give all of you a very warm welcome to Investorshub. Thank you all for coming. The owners of this Website are very nice and very helpful. I am not the owner of anything here. I am only, at the present the Chairman.
A difference of opinions and views are welcome. The only thing that is not welcomed at the investment message boards are Personal Attackers or when a few posters get into a angry heated discussion with one another and it gets out of hand. If that happens the posters involved will be asked to take it to the Parking Lot...LOL.....they have an area for that......Really they do! They also have a Sheriff's Office.....LOL. Here is the link to investigate it for your self: http://www.investorshub.com/beta/boards.asp?cat_id=130 It explains what the areas are for. I hope you all enjoy this place as much as I do.
If you have a problem or need help just go to the box at the bottom of this or any page. If no one is there at the time you need help, leave a message and they will answer you as soon as they can.
NUTTS.....I do not have any information about ACE. If you or anyone can provide some with a back up link I will be happy to include it in the Information Box. It is a part of NWLL/NWL and should be included.
HEADLINES FOR : WEBT From CBS MarkeWatch
http://www2.marke****ch.com/news/search.asp?source=blq/ask&searchoption=ticker&query=WEBT
Francois.....SCIOS NASDAQ stock is now here under Biopharmaceutical of listed stocks.
Press release
09/07/2000 08:01 EDT http://www.prnewswire.com
Scios VMAC Clinical Trial Data to Be Presented at American Heart Association'sClinical Trial Results Plenary Session
Cleveland Clinic's Jim Young, M.D. to Present Clinical Trial Data
SUNNYVALE, Calif., Sept. 7 /PRNewswire/ -- Scios Inc. (Nasdaq: SCIO) today announced that results of the VMAC (Vasodilation in the Management of Acute Congestive heart failure) clinical trial with the company's lead product, Natrecor(R) (nesiritide), will be presented at the Clinical Trial Results plenary session on Wednesday, November 15 during the 73rd Scientific Session of the American Heart Association meeting in New Orleans.
"I am delighted that the AHA invited us to present the VMAC data at the Scientific Session meeting in November", said James B. Young, M.D., chairman of the VMAC Steering Committee and Head, Section of Heart Failure and Cardiac Transplant Medicine at The Cleveland Clinic Foundation. "It provides an ideal opportunity to present important new data to a large and clinically relevant group. It is also a tremendous opportunity to educate this important audience about the underecognized problem of acute congestive heart failure and a potential new treatment option."
Enrollment in the VMAC trial was completed at the end of July and patient follow-up, data collection and analysis are now underway. Typically, the Clinical Trial Results plenary sessions accommodate four or five presentations of about 15 minutes each, with a press conference preceding the session. Usually the session is attended by thousands of cardiologists and scientists interested in the various topics presented.
"This presentation will create unparalleled visibility for Natrecor and the VMAC clinical data among our key target audience," said Richard B. Brewer, Scios' president and chief executive officer. "Because the AHA's embargo policy does not allow presentation or announcement of late-breaking clinical trial data prior to the news conference and presentation, we have changed our target date to announce VMAC data results from late October to November 15, timed with Dr. Young's presentation at AHA."
Natrecor will be the subject of another poster presentation during the AHA conference. A copy of this abstract may be obtained from the AHA website beginning in October (www.scientificsessions.org) or by contacting Scios' Investor Relations department at 408-616-8325.
Scios expects to file a NDA amendment for Natrecor by the end of 2000. Last month, positive Phase III acute CHF results from previous Natrecor clinical trials were published in The New England Journal of Medicine. The safety and efficacy of this compound will be determined by the U.S. Food and Drug Administration as part of the market registration process.
About the VMAC Study
The VMAC study is a randomized, double-blind, Phase III trial that evaluated the hemodynamic and clinical effects of Natrecor, placebo and IV nitroglycerin when used for the treatment of acutely decompensated CHF in a typical hospital setting. The trial enrolled 480 patients in 62 centers across the United States.
Patients enrolling in the trial will be randomized into one of four treatment groups, receiving either Natrecor (fixed dose), Natrecor (adjustable dose), nitroglycerin or placebo. Natrecor subjects will receive a 2 ug/kg IV bolus, followed by an infusion of 0.01 ug/kg/min. In the Natrecor adjustable dose arm, the Natrecor infusion may be adjusted according to a protocol-specific prescription. The dosing regimen of nitroglycerin will be adjusted to achieve the desired clinical or hemodynamic effect, according to the usual practice of the Investigator. The primary analysis will evaluate the effects of Natrecor plus standard care compared to placebo plus standard care at 3 hours; the primary endpoints are pulmonary capillary wedge pressure (PCWP) and the patient's dyspnea (shortness of breath) evaluation. Secondary endpoints are to compare the hemodynamic and clinical effects of Natrecor with IV nitroglycerin. Patients eligible to enroll in the study are those who:
-- Require hospitalization and IV therapy for at least 24 hours;
-- Have dyspnea at rest or with minimal activity; and
-- Exhibit elevated cardiac filling pressures.
Scios Inc.
Scios is a biopharmaceutical company engaged in the discovery, development, and commercialization of novel human therapeutics. Scios has commercial or research and development relationships with Chiron Corporation, DuPont Pharmaceuticals Company; Eli Lilly and Company; GenVec, Inc.; Kaken Pharmaceutical Co., Ltd.; and Novo Nordisk A/S, of Denmark. Additional information on Scios is available at its web site located at www.sciosinc.com and in the company's various filings with the Securities and Exchange Commission.
The statements in this press release that are not historical facts are forward-looking statements that involve risks and uncertainties. These include the risks concerning the success of the VMAC trial and regulatory approval of Natrecor, as well as other risks detailed from time to time in the reports filed by Scios with the SEC, including the company's annual report on form 10-K for the year ended December 31, 1999 and subsequent reports on form 10-Q.
SOURCE Scios Inc.
CO: Scios Inc., American Heart Association; Cleveland Clinic Foundation
ST: California, Louisiana, Ohio
IN: MTC BIO
SU: TDS
Press Release
http://biz.yahoo.com/prnews/000829/ca_scios_m.html
Tuesday August 29, 2:01 pm Eastern Time
SOURCE: Scios Inc.
Scios Announces Medical Affairs Vice President
SUNNYVALE, Calif., Aug. 29 /PRNewswire/ -- Scios Inc. (Nasdaq: SCIO - news) today announced the promotion of Darlene Horton, M.D. to the position of Vice President, Medical Affairs. Dr. Horton will also become a member of the Corporate Management Committee. Dr. Horton has been with Scios since 1996, most recently as Senior Director, Clinical Research and Clinical Information Systems.
Responsibilities of Dr. Horton's new position include overseeing the clinical research and clinical information systems groups at Scios. Richard B. Brewer, President and Chief Executive Officer of Scios, noted that, ``Dr. Horton's leadership of the Natrecor development program is evident by the on-schedule completion of the VMAC trial last month. She was instrumental in the design of the trial, strategically directing the complex protocol based on FDA and outside expert input. Dr. Horton's experience as a practicing cardiologist will be extremely useful in the development of additional clinical programs for Natrecor as we near approval.''
Dr. Horton received her medical degree from the University of Florida, Gainesville in 1988. Dr. Horton completed her residency in the Department of Pediatrics at the University of California, San Francisco. Prior to joining Scios, Dr. Horton completed her fellowship in pediatric cardiology at UCSF's Cardiovascular Research Institute, during which time her clinical and research focus was adult electrophysiology.
Scios Inc.
Scios is a biopharmaceutical company engaged in the discovery, development, and commercialization of novel human therapeutics. Scios has commercial or research and development relationships with Chiron Corporation, DuPont Pharmaceuticals Company; Eli Lilly and Company; GenVec, Inc.; Kaken Pharmaceutical Co., Ltd.; and Novo Nordisk A/S, of Denmark. Additional information on Scios is available at its web site located at www.sciosinc.com and in the company's various filings with the Securities and Exchange Commission.
The statements in this press release that are not historical facts are forward-looking statements that involve risks and uncertainties. These include the risks concerning the success of the VMAC trial, regulatory approval of Natrecor as a treatment for acute decompensated CHF, and development of additional clinical uses for Natrecor, as well as other risks detailed from time to time in the reports filed by Scios with the SEC, including the company's annual report on form 10-K for the year ended December 31, 1999 and subsequent reports on form 10-Q.
SOURCE: Scios Inc.
******ABOUT SCIO******
home web page: http://www.sciosinc.com/webpage_templates/main.php3
Corporate Profile:
http://www.sciosinc.com/webpage_templates/sec2.php3?page_name=corp_overview
Company Overview:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=co_overview
Strategic Partnerships:
http://www.sciosinc.com/webpage_templates/strat.php3?page_name=strat_partner
Key Management:
http://www.sciosinc.com/webpage_templates/key_mgmt.php3?page_name=key_mgmt
Psychiatric Sales:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=comm_ops
Scientific Advisory Board:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=sci_advisory
Clinical Programs:
http://www.sciosinc.com/webpage_templates/sec2.php3?page_name=clin_prog
Pipeline:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=cp_pipeline
Natrecor:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=natrecor
Fiblast:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=fiblast
VEGF:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=vegf
P38 Kinase:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=p38_kinase
Research and Development:
http://www.sciosinc.com/webpage_templates/sec2.php3?page_name=r_d
Pipeline:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=pipeline
Discovery Research:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=research
Research Technology:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=research_tech
Development:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=prod_dev
Biopharmaceutical Development:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=protein_chem
Analytical Methods and Quality Control:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=analytical_chem
Pharmaceutics Groups:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=pharm_groups
Quality and Compliance:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=quality_compliance
Career Opportunities, Here you will find current Opportunities, benefits and employees insights:
http://www.sciosinc.com/webpage_templates/sec2.php3?page_name=career_opps
Investors Relations, Here you will find FAQ, Financial Information, Up coming Events, Request for Information,
Contact Scios Investor Relations, Investor's Brief (PDF Format), Email Alert, Breaking Scientific News and the 1999 Annual Report.
http://www.sciosinc.com/webpage_templates/sec2.php3?page_name=i_r
Scios News and Current Press Releases:
http://www.sciosinc.com/webpage_templates/news.php3?page_name=news
Publications:
http://www.sciosinc.com/webpage_templates/tert.php3?page_name=pubs
Press Release Archive:
http://www.sciosinc.com/webpage_templates/news.php3?page_name=press_release_archive
How to Contact Scios:
http://www.sciosinc.com/webpage_templates/sec2.php3?page_name=contact
Francois...hereis the home page link. One has to sign up, but like I said it is free'
http://www.money.net/
Here is where I go for the quotes Not sure if will come up for you because I have to hit log in then Real-Time portfolio/quotes area to bring up the level 2 type moving screen. It is really nice once it is set up. It also has a streaming ticker. But don't need it with the constant moving levels of trade of all your stocks listed. Yhey have 2 screens the one I have is good they also have one called screaming the one I have is screaming enough for me.....LOL
DONTGIVEUP...I will talk to MATT and get you set up. Thanks
this is so nice of you.